News
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.
But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
During a recent finance committee meeting, Deputy Comptroller Delano Dowell confirmed to the Common Council that so far in fiscal year 2024-2025, Buffalo has incumbered $2.1 million of unexpected ...
Medical conditions can limit which weight loss pills work safely for you. For example, you should avoid phentermine if you ...
Weight loss pills are generally safe when taken under proper medical supervision with awareness of potential side effects.
To curb hunger and help achieve weight loss, some natural alternatives to Ozempic (semaglutide) may help. See what the ...
Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid or state employee insurance programs are scrambling to lessen the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results